183 related articles for article (PubMed ID: 19438511)
1. Statins inhibit the growth of variant human embryonic stem cells and cancer cells in vitro but not normal human embryonic stem cells.
Gauthaman K; Manasi N; Bongso A
Br J Pharmacol; 2009 Jul; 157(6):962-73. PubMed ID: 19438511
[TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of the effects of statins on human stem and cancer cells in vitro.
Gauthaman K; Richards M; Wong J; Bongso A
Reprod Biomed Online; 2007 Nov; 15(5):566-81. PubMed ID: 18028750
[TBL] [Abstract][Full Text] [Related]
3. Effect of ROCK inhibitor Y-27632 on normal and variant human embryonic stem cells (hESCs) in vitro: its benefits in hESC expansion.
Gauthaman K; Fong CY; Bongso A
Stem Cell Rev Rep; 2010 Mar; 6(1):86-95. PubMed ID: 20013076
[TBL] [Abstract][Full Text] [Related]
4. Self-renewal and differentiation capabilities are variable between human embryonic stem cell lines I3, I6 and BG01V.
Tavakoli T; Xu X; Derby E; Serebryakova Y; Reid Y; Rao MS; Mattson MP; Ma W
BMC Cell Biol; 2009 Jun; 10():44. PubMed ID: 19500347
[TBL] [Abstract][Full Text] [Related]
5. BG01V: a variant human embryonic stem cell line which exhibits rapid growth after passaging and reliable dopaminergic differentiation.
Zeng X; Chen J; Liu Y; Luo Y; Schulz TC; Robins AJ; Rao MS; Freed WJ
Restor Neurol Neurosci; 2004; 22(6):421-8. PubMed ID: 15798361
[TBL] [Abstract][Full Text] [Related]
6. Statins, stem cells, and cancer.
Gauthaman K; Fong CY; Bongso A
J Cell Biochem; 2009 Apr; 106(6):975-83. PubMed ID: 19224538
[TBL] [Abstract][Full Text] [Related]
7. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
Hoque A; Chen H; Xu XC
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
[TBL] [Abstract][Full Text] [Related]
8. Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
Ogunwobi OO; Beales IL
Am J Gastroenterol; 2008 Apr; 103(4):825-37. PubMed ID: 18371146
[TBL] [Abstract][Full Text] [Related]
9. Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins.
Perchellet JP; Perchellet EM; Crow KR; Buszek KR; Brown N; Ellappan S; Gao G; Luo D; Minatoya M; Lushington GH
Int J Mol Med; 2009 Nov; 24(5):633-43. PubMed ID: 19787197
[TBL] [Abstract][Full Text] [Related]
10. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells.
Sivaprasad U; Abbas T; Dutta A
Mol Cancer Ther; 2006 Sep; 5(9):2310-6. PubMed ID: 16985065
[TBL] [Abstract][Full Text] [Related]
11. In vitro mechanisms of lovastatin on lung cancer cell lines as a potential chemopreventive agent.
Maksimova E; Yie TA; Rom WN
Lung; 2008; 186(1):45-54. PubMed ID: 18034278
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
13. Investigation of simvastatin-induced apoptosis and cell cycle arrest in cancer stem cells of MCF-7.
Afzali M; Vatankhah M; Ostad SN
J Cancer Res Ther; 2016; 12(2):725-30. PubMed ID: 27461641
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Barret's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins.
Konturek PC; Burnat G; Hahn EG
J Physiol Pharmacol; 2007 Aug; 58 Suppl 3():141-8. PubMed ID: 17901590
[TBL] [Abstract][Full Text] [Related]
15. Effect of antibiotics against Mycoplasma sp. on human embryonic stem cells undifferentiated status, pluripotency, cell viability and growth.
Romorini L; Riva DA; Blüguermann C; Videla Richardson GA; Scassa ME; Sevlever GE; Miriuka SG
PLoS One; 2013; 8(7):e70267. PubMed ID: 23936178
[TBL] [Abstract][Full Text] [Related]
16. Statins decrease the expression of c-Myc protein in cancer cell lines.
Rao PS; Rao US
Mol Cell Biochem; 2021 Feb; 476(2):743-755. PubMed ID: 33070276
[TBL] [Abstract][Full Text] [Related]
17. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
18. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC
Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187
[TBL] [Abstract][Full Text] [Related]
19. Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-kappaB pathway.
Ahn KS; Sethi G; Aggarwal BB
Biochem Pharmacol; 2008 Feb; 75(4):907-13. PubMed ID: 18036510
[TBL] [Abstract][Full Text] [Related]
20. [In vitro effects of mevastatin on the proliferation and apoptosis in human multiple myeloma cell line U266].
Liu ZL; Luo JM; Dong ZR; Wang FX; Zhang XJ; Yang JC; Du XY; Yao L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):340-5. PubMed ID: 15228663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
